Arquivo para October 12th, 2020
Pandemic fatigue and vaccine rush
12
Oct
WHO in its Europe office has released a document explaining
a “pandemic fatigue” estimating that 60% of the population is already at this stage.
Hans Henri Kluge, WHO´s regional director for Europe, says tiredness was already expected at this stage of the crisis: “since the virus arrived on the European continent eight months ago, citizens have made enormous sacrifices to contain the covid-19 , the cost was very high, something that exhausted us all, regardless of what we live or what we do. In these circunstancies it is easy and natural to feel listless, unmotivated, to feel tired”, he said to BBC News.
The measures that aim to continue the efforts to obtain a common center to seek common sense in the solution of the issue: understand the people who are doing it regularly and involve communities in debates and decisions, allow people to live their lives, but risks and seeking creative solutions, as it has been like virtual meetings, such as deliveries of food and consumer products, especially to vulnerable people.
The other worrying issue is a race for the vaccine, which should follow exclusively medical routes, but already point to a specific formation of profit with people, so the first vaccine to arrive on the market will not necessarily be the best, and to make politicians worse try to take advantage of this race.
Brazilian doctors are cautious, like Dr. Álvaro Furtado costa, infectious disease physician at HC-FMUSP: “everyone is very optimistic, but the study of the vaccine is very complicated, most of them stop in phase 3 of clinical tests, due to the problems that appear. It is important to discuss this possibility (of not having a vaccine) ”, and reaching stage 3 does not mean that it is nearing the end, as most vaccines stop at this stage, as are the cases of HIV and chikungunya.
What should be done in this case is to continue the search for medications that decrease the mortality rate and, therefore, recover those infected, for example, by the SARS-Cov-2 virus, and the clinical trial is also developed in Brazil by FioCruz , which partners with Solidarity International, from WHO, and in the country are in 18 hospitals in 12 states, with research on different medications.
The final stage of phase 3 is much more difficult to reach and it is not the political propaganda that solves it, but the health control agencies of the drugs.
